CN Patent

CN108137585B — 杂环化合物及其应用

Assigned to Oppner Biology Co ltd · Expires 2021-10-22 · 5y expired

What this patent protects

本文提供了式(I)的杂环化合物、包含这种化合物的药物组合物以及它们的治疗应用、用于它们的制备的方法、中间化合物、包含这种化合物的药物组合物以及它们的治疗应用。

USPTO Abstract

本文提供了式(I)的杂环化合物、包含这种化合物的药物组合物以及它们的治疗应用、用于它们的制备的方法、中间化合物、包含这种化合物的药物组合物以及它们的治疗应用。

Drugs covered by this patent

pexidartinib-hydrochloride (PEXIDARTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN108137585B
Jurisdiction: CN
Classification: —
Expires: 2021-10-22
Drug substance claim: No
Drug product claim: No
Assignee: Oppner Biology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.